TCR-ENGINEERED INKT CELLS INDUCE ROBUST ANTI-TUMOR RESPONSE BY DUAL TARGETING CANCER AND SUPPRESSIVE MYELOID CELLS

被引：0
|
作者：
Delfanti, G. [1 ]
Cortesi, F. [1 ]
Perini, A. [1 ]
Azzimonti, L. [2 ]
De Lalla, C. [1 ]
Garavaglia, C. [1 ]
Squadrito, M. [3 ]
Consonni, M. [1 ]
Re, F. [4 ]
Shen, H. [5 ]
Dellabona, P. [1 ]
Casorati, G. [1 ]
机构：
[1] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy
[2] Supsi Usi, IDSIA, Manno, Switzerland
[3] San Raffaele Telethon Inst Gene Therapy SRTIGET, Targeted Canc Gene Therapy Unit, Milan, Italy
[4] Univ Milano Bicocca, Bionanomed Ctr Nanomib, Sch Med & Surg, Monza, Italy
[5] Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA
来源：
HUMAN GENE THERAPY | 2023年 / 34卷 / 21-22期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O007
引用
收藏
页码：A4 / A4
页数：1
相关论文
共 50 条
  • [1] TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells
    Delfanti, Gloria
    Cortesi, Filippo
    Perini, Alessandra
    Antonini, Gaia
    Azzimonti, Laura
    de Lalla, Claudia
    Garavaglia, Claudio
    Squadrito, Mario L.
    Fedeli, Maya
    Consonni, Michela
    Sesana, Silvia
    Re, Francesca
    Shen, Haifa
    Dellabona, Paolo
    Casorati, Giulia
    [J]. SCIENCE IMMUNOLOGY, 2022, 8 (90)
  • [2] Targeting pancreatic cancer with TCR-engineered T cells
    Greenberg, Philip D.
    Anderson, Kristin G.
    Egan, Dan
    Hingorani, Sunil R.
    Nezi, Luigi
    Manzo, Teresa
    Oda, Shannon K.
    Paulson, Kelly G.
    Perret, Rachel
    Schmidt, Leah
    Schmitt, Tom M.
    Stromnes, Ingunn M.
    Chapuis, Aude G.
    [J]. CANCER RESEARCH, 2019, 79 (24)
  • [3] Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer
    Sarhan, Dhifaf
    Eisinger, Silke
    He, Fei
    Bergsland, Maria
    Pelicano, Catarina
    Driescher, Caroline
    Westberg, Kajsa
    Benitez, Itziar Ibarlucea
    Humoud, Rawan
    Palano, Giorgia
    Li, Shuijie
    Carannante, Valentina
    Muhr, Jonas
    Onfelt, Bjorn
    Schlisio, Susanne
    Ravetch, Jeffrey, V
    Heuchel, Rainer
    Lohr, Matthias J.
    Karlsson, Mikael C., I
    [J]. ISCIENCE, 2022, 25 (11)
  • [4] Affinity-Enhanced TCR-Engineered T Cells Induce Antimyeloma Responses
    不详
    [J]. CANCER DISCOVERY, 2015, 5 (09) : 901 - 901
  • [5] Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment
    Delfanti, Gloria
    Dellabona, Paolo
    Casorati, Giulia
    Fedeli, Maya
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [6] The induction of iNKT cells and CIK cells toward anti-tumor phenotypes
    Wongkajornsilp, Adisak
    Htwe, Khin Su Su
    Sawatpiboon, Nathawadee
    Duangsa-ard, Sunisa
    Kasetsinsombat, Kanda
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [7] IMPROVED ANTI-TUMOR ACTIVITY OF NEXT-GENERATION TCR-ENGINEERED T CELLS THROUGH CD8 CO-EXPRESSION
    Bajwa, Gagan
    Gunesch, Justin
    Azoulay-Alfaguter, Inbar
    Mata, Melinda
    Mohamed, Ali
    Kalra, Mamta
    Walter, Steffen
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A173 - A173
  • [8] Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma
    Hotblack, Alastair
    Holler, Angelika
    Piapi, Alice
    Ward, Sophie
    Stauss, Hans J.
    Bennett, Clare L.
    [J]. MOLECULAR THERAPY, 2018, 26 (06) : 1471 - 1481
  • [9] Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
    Shafer, Paul
    Kelly, Lauren M.
    Hoyos, Valentina
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations
    Chhabra, Arvind
    [J]. THESCIENTIFICWORLDJOURNAL, 2011, 11 : 121 - 129
12345